Price movement over the last 24 hours
AdaptHealth Corp vs Cisco Systems Inc — how do they compare? AdaptHealth Corp trades at $10.04 (market cap $1.38B), while Cisco Systems Inc trades at $113.81 (market cap $440.61B). The key difference: Cisco Systems Inc is far larger — about 319.3× AdaptHealth Corp's market cap, and Cisco Systems Inc pays a 1.5% dividend while AdaptHealth Corp pays none. Which is the better fit depends on your goals.
| AHCO | CSCO | |
|---|---|---|
Market Cap | $1.38B | $440.61B |
Sector | Health | Technology |
52-Week High | $13.38 | $130.00 |
52-Week Low | $8.68 | $66.20 |
Enterprise Value | $3.33B | $455.28B |
Volume | — | 22,887,319 |
Dividend Yield | — | 1.5% |
Signals from Pluang's Aura AI — not financial advice
AdaptHealth (AHCO) trades at $10.27, down 4.55% today, with neutral technical signals and mixed fundamental performance. The company reported Q1 2026 earnings miss with negative EPS of -$0.06 versus $0.0125 expected, continuing a pattern of recent quarterly misses. Despite revenue growth to $3.3B projected for 2026, net income remains negative with -2.43% margin. Analyst consensus remains bullish with 75% buy ratings and $14.80 price target, representing 44% upside potential from current levels.
The investment case balances strong analyst support and reasonable valuation (P/S 0.42, EV/EBITDA 7.17) against persistent profitability challenges. Recent refinancing improves financial flexibility, but execution on cost controls and margin improvement remains critical. The stock offers significant upside if management can translate revenue growth into sustainable profitability, though current negative earnings trend presents near-term headwinds.
Cisco Systems (CSCO) trades at $113.98, up 1.14% on the day, with a technical picture showing bearish momentum indicators but recent positive earnings beats. The company reported Q1 2026 EPS of $1.06, beating expectations of $1.03, continuing a trend of outperformance. Recent news highlights Cisco's strategic push into AI cybersecurity, announcing new software tools and partnerships at Cisco Live 2026. Valuation metrics appear elevated with a P/E of 37.99 and P/S of 7.48, though profitability remains strong with a 64.33% gross margin.
The outlook balances strong analyst support (52% buy ratings with $130.38 consensus target) against high valuation multiples and mixed technical signals. Investment opportunity centers on Cisco's AI infrastructure and cybersecurity positioning, while risks include execution in transitioning growth drivers, competitive pressures, and potential margin compression if revenue growth slows.
Trailing returns across standard periods
AdaptHealth provides patient-centered healthcare-at-home solutions in the U.S. It offers medical equipment and supplies for sleep therapy, respiratory health, diabetes management, and general home wellness.
Read more on AHCO →Cisco Systems, Inc. provides information technology and networking services. The Company offers enterprise network security, software development, data collaboration, cloud computing, and other related services. Cisco Systems serves customers in the United States.
Read more on CSCO →